Diagnomics

Diagnomics envisions a future where cooperation between patients, physicians, and scientists enables a truly personalized medicine which recognizes patients as unique individuals and arms them with more accurate information about their genetic make-up. We are at the dawn of a new era in personalized medicine which allows us to use more effective therapies and treatments based on better insight into disease and personal health. Our vision is to develop complete solutions for personal genome profiling, sequencing and annotation, with the ultimate goal of integrating individual genomic sequencing into routine medical care. Diagnomics seeks to embrace the incredibly bright and hopeful future that personalized medicine provides, leading to improving individual well being. Diagnomics has a highly qualified team of scientists including early pioneers in sequencing the human genome. Additionally, Diagnomics has cutting edge genome presentation software as well as genome discovery expertise to guide the development of novel diagnostic tools and new therapeutic targets. Diagnomics opened its CLIA laboratory in 2016 and is accredited by the California Department of Public Health (CDPH). Established in 2011, Diagnomics is one of the first Next Generation Sequencing (NGS)-based genomics companies located in California.